Key Takeaways
- Nike’s fiscal Q1 2027 results arrive Tuesday after the bell, with analysts anticipating a 2.2% revenue decline compared to last year.
- KeyCorp forecasts earnings per share of $0.46 for Q1 2027, while the full-year consensus stands at $1.49.
- Shares opened Monday at $40.76, hovering just above the 52-week low of $40.00, declining 10.9% in the last 30 days.
- Analyst consensus shows 14 Buy, 19 Hold, and 3 Sell ratings, with an average price target of $59.01.
- In April, CEO Elliott Hill acquired more than $1 million in shares, increasing his direct holdings by 9.79%.
As Nike (NKE) stock prepares for its Tuesday earnings announcement, shares are trading uncomfortably close to their annual bottom of $40.00. Monday’s opening price of $40.76 reflects a challenging month that saw the stock drop 10.9%, significantly trailing the consumer discretionary sector’s 4.2% gain during the same timeframe.
The athletic apparel giant will release its quarterly results after the closing bell Tuesday. Wall Street forecasts show revenue declining 2.2% on a year-over-year basis, though this represents substantial progress compared to the 12% contraction reported in the comparable quarter last year.
During the previous reporting period, Nike exceeded analyst projections. The company reported earnings of $0.35 per share, surpassing the consensus estimate of $0.29 by six cents. Revenue totaled $11.28 billion, slightly above the anticipated $11.23 billion. Year-over-year revenue growth was essentially flat, registering just 0.1%.
Analyst A. Owens from KeyCorp released updated projections for Nike prior to the earnings release. The firm anticipates Q1 2027 earnings of $0.46 per share, Q2 at $0.59, Q3 at $0.44, and Q4 at $0.26. The full-year consensus projection remains at $1.49 per share.
Wall Street Lowers Price Targets While Maintaining Cautious Optimism
Analyst sentiment reflects measured caution. Multiple analysts adjusted their price targets downward in early April. Truist Financial reduced its forecast from $69 to $57 while preserving its Buy recommendation. Robert W. Baird lowered its target from $85 to $70 while maintaining an Outperform designation. Jefferies trimmed its target from $110 to $90, also keeping a Buy rating intact.
CICC Research took a more conservative stance, downgrading Nike from Outperform to Market Perform and slashing its price target from $69 to $58. Weiss Ratings adopted an even more bearish position, deepening its Sell rating in June.
Among 36 covering analysts, the current distribution includes 14 Buy recommendations, 19 Hold ratings, and 3 Sell calls, resulting in an overall Hold consensus with an average price objective of $59.01. This target represents substantial upside from the current trading level around $40.91.
Nike has fallen short of Wall Street’s revenue projections on several occasions throughout the past two years, potentially explaining why analyst forecasts have remained largely unchanged over the last 30 days rather than being adjusted upward prior to this report.
Executive Stock Purchases Signal Confidence
A notable development preceding the earnings release: CEO Elliott Hill acquired 23,660 shares during April at an average cost of $42.27 per share, representing a purchase value exceeding $1 million. This transaction increased his direct stake by 9.79%, bringing his total ownership to 265,247 shares.
Board member John W. Rogers Jr. similarly purchased 4,000 shares in April at $43.34. Collectively, company insiders have acquired 64,441 shares valued at approximately $2.73 million throughout the past three months.
Institutional ownership accounts for 64.25% of outstanding shares. Multiple funds executed modest position increases during the fourth quarter.
Nike maintains a quarterly dividend of $0.41 per share, payable July 1, translating to a 4.0% annual yield. However, the dividend payout ratio currently registers at 108.61%, indicating the company is distributing more than it earns — a sustainability metric investors are monitoring carefully.
The stock’s 50-day moving average stands at $44.19, while its 200-day moving average sits at $53.89, both positioned substantially above the present share price.
